2026-04-28 – Press Releases – www.prnewswire.com

TOKYO, April 28, 2026 /PRNewswire/ — Cordis, a global leader in interventional cardiovascular technologies, today announces the launch and availability of the SELUTION SLR PTA Drug-Eluting Balloon (DEB)1 for use in Japan. SELUTION SLR DEB is designed to deliver sirolimus in a…

Read the full article here.

About Us

Your go-to source for comprehensive research and comparisons of top-quality health supplements. We provide unbiased insights through meticulous analysis, offering accurate, evidence-based information to help you make informed decisions.

References

Awards

© 2024 by Health Supplements Review.